Global Retirement Partners LLC trimmed its position in Xylem Inc. (NYSE:XYL – Get Rating) by 34.8% during the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 1,089 shares of the industrial products company’s stock after selling 582 shares during the quarter. Global Retirement Partners LLC’s holdings in Xylem were worth $112,000 at the end of the most recent quarter.
Other large investors also recently modified their holdings of the company. Glassman Wealth Services boosted its position in Xylem by 16.2% during the 2nd quarter. Glassman Wealth Services now owns 788 shares of the industrial products company’s stock worth $62,000 after acquiring an additional 110 shares during the period. Albion Financial Group UT raised its stake in shares of Xylem by 1.0% in the 3rd quarter. Albion Financial Group UT now owns 11,491 shares of the industrial products company’s stock worth $1,004,000 after buying an additional 112 shares in the last quarter. Private Capital Group LLC raised its stake in shares of Xylem by 2.5% in the 2nd quarter. Private Capital Group LLC now owns 4,830 shares of the industrial products company’s stock worth $378,000 after buying an additional 118 shares in the last quarter. Trust Co. of Vermont raised its stake in shares of Xylem by 2.0% in the 3rd quarter. Trust Co. of Vermont now owns 7,267 shares of the industrial products company’s stock worth $635,000 after buying an additional 140 shares in the last quarter. Finally, Personal CFO Solutions LLC raised its stake in shares of Xylem by 2.4% in the 3rd quarter. Personal CFO Solutions LLC now owns 5,990 shares of the industrial products company’s stock worth $523,000 after buying an additional 143 shares in the last quarter. 83.57% of the stock is currently owned by hedge funds and other institutional investors.
Insider Transactions at Xylem
In other news, SVP Matthew Francis Pine sold 11,870 shares of the company’s stock in a transaction dated Friday, November 4th. The stock was sold at an average price of $107.12, for a total transaction of $1,271,514.40. Following the completion of the sale, the senior vice president now owns 22,819 shares in the company, valued at approximately $2,444,371.28. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. 0.89% of the stock is currently owned by corporate insiders.
Xylem Stock Performance
Xylem (NYSE:XYL – Get Rating) last released its quarterly earnings results on Tuesday, November 1st. The industrial products company reported $0.79 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.66 by $0.13. The company had revenue of $1.38 billion during the quarter, compared to the consensus estimate of $1.33 billion. Xylem had a return on equity of 14.40% and a net margin of 5.97%. Analysts anticipate that Xylem Inc. will post 2.71 earnings per share for the current fiscal year.
Xylem Dividend Announcement
The business also recently declared a quarterly dividend, which was paid on Tuesday, December 20th. Stockholders of record on Tuesday, November 22nd were paid a dividend of $0.30 per share. The ex-dividend date was Monday, November 21st. This represents a $1.20 annualized dividend and a dividend yield of 1.16%. Xylem’s dividend payout ratio (DPR) is presently 68.18%.
Wall Street Analyst Weigh In
A number of research firms have recently commented on XYL. Mizuho boosted their price objective on Xylem from $88.00 to $105.00 and gave the stock a “neutral” rating in a research note on Friday, January 13th. Atlantic Securities raised Xylem from a “neutral” rating to an “overweight” rating and boosted their price objective for the stock from $110.00 to $129.00 in a research note on Wednesday, November 16th. Stifel Nicolaus raised Xylem from a “hold” rating to a “buy” rating and boosted their target price for the stock from $115.00 to $124.00 in a research report on Tuesday. StockNews.com upgraded Xylem from a “hold” rating to a “buy” rating in a report on Tuesday. Finally, Morgan Stanley lifted their price target on Xylem from $105.00 to $115.00 and gave the company an “overweight” rating in a report on Wednesday, January 18th. One analyst has rated the stock with a sell rating, five have issued a hold rating and seven have issued a buy rating to the company’s stock. According to data from MarketBeat, the company presently has an average rating of “Hold” and an average target price of $114.50.
Xylem, Inc engages in the design, manufacture, and application of engineered technologies for the water industry. It operates through the following business segments: Water Infrastructure, Applied Water, and Measurement and Control Solutions. The Water Infrastructure segment focuses on the transportation, treatment and testing of water.
- Get a free copy of the StockNews.com research report on Xylem (XYL)
- Pliant Therapeutics Gaps 34% Higher: More Upside To Come?
- How Will Early 2023 Layoffs Affect These 5 Biotech Stocks?
- Is the Pain Over for Baudax Bio Investors after a 70% Spike?
- Will Rocket Lab’s First U.S. Launch Send Stock Into Stratosphere?
- 3 Retail Stocks Ringing the Register in 2023
Receive News & Ratings for Xylem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Xylem and related companies with MarketBeat.com's FREE daily email newsletter.